This proposal addresses two important areas in the pathogenesis of HIV-1 infection: (1) What cellular pathways contribute to viral replication, particularly in the early """"""""subclinical"""""""" stages of disease? What cells are infected at mucosal surfaces, how is virus transmitted to T cells, and why does viral replication proceed chronically at substantial levels even in asymptomatic individuals? (2) What are the mechanisms whereby CD4+ T cells are lost, particularly T cells that mediate immunologic memory? Why is the loss of CD4+ T cells, like viral replication, apparently a chronic process such that HIV-1 infected individuals may lose > 109 CD4+ T cells each day? The overall hypothesis is that dendritic cells [DCs] play an important role in both areas of pathogenesis, because of the capacity of DCs to express CD4 and to interact with CD4+ memory T cells in mucosal and extravascular sites. To model mucosal leukocytes, the PI has studied DCs and T cells from skin. He finds that small amounts of virus in DCs can, in the presence of CD4+ T cells, lead to HIV-1 replication and apoptotic T cell death in the absence of exogenous stimuli. He have now visualized productive infection of DCs in mucosa of infected patients early in the course of their disease. He will now pursue 3 sets of questions on DC function in situ and in vitro: (1) Are productively infected DCs [identified with a panel of new antibodies to DCs] present in several different mucosal tissues, and in cells isolated from afferent lymph? (2) What are the viral and cellular requirements for vigorous replication of HIV-1 in mixtures of skin derived DCs and T cells? He will emphasize fresh viral isolates from asymptomatic patients, and a group of adhesion and costimulatory molecules that mediate the DC-T cell interaction. (3) What are the viral and cellular requirements for the apoptotic killing of CD4+ memory T cells? He will pursue preliminary findings for bystander killing of noninfected T cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI040045-02
Application #
2390451
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Project Start
1996-04-01
Project End
2001-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Genetics
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Mollah, Shamim A; Dobrin, Joseph S; Feder, Rachel E et al. (2014) Flt3L dependence helps define an uncharacterized subset of murine cutaneous dendritic cells. J Invest Dermatol 134:1265-1275
Anandasabapathy, Niroshana; Feder, Rachel; Mollah, Shamim et al. (2014) Classical Flt3L-dependent dendritic cells control immunity to protein vaccine. J Exp Med 211:1875-91
Park, Chae Gyu; Rodriguez, Anthony; Steinman, Ralph M (2012) PE-Cy5.5 conjugates bind to the cells expressing mouse DEC205/CD205. J Immunol Methods 384:184-90
Park, Chae Gyu; Rodriguez, Anthony; Ueta, Hisashi et al. (2012) Generation of anti-human DEC205/CD205 monoclonal antibodies that recognize epitopes conserved in different mammals. J Immunol Methods 377:15-22
Idoyaga, Juliana; Lubkin, Ashira; Fiorese, Christopher et al. (2011) Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci U S A 108:2384-9
Nchinda, Godwin; Amadu, David; Trumpfheller, Christine et al. (2010) Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells. Proc Natl Acad Sci U S A 107:4281-6
Cheong, Cheolho; Choi, Jae-Hoon; Vitale, Laura et al. (2010) Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody. Blood 116:3828-38
Cheong, Cheolho; Matos, Ines; Choi, Jae-Hoon et al. (2010) Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143:416-29
Zaba, Lisa C; Fuentes-Duculan, Judilyn; Eungdamrong, Narat John et al. (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 129:79-88
Nchinda, Godwin; Kuroiwa, Janelle; Oks, Margarita et al. (2008) The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J Clin Invest 118:1427-36

Showing the most recent 10 out of 51 publications